Moreover, the 36-month beta value for NRXP is 1.23. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NRXP is 9.20M and currently, short sellers hold a 6.52% of that float. On December 26, 2024, NRXP’s average trading volume was 193.72K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NRXP) stock’s latest price update
The stock price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) has surged by 10.56 when compared to previous closing price of 1.42, but the company has seen a 3.05% gain in its stock price over the last five trading sessions. zacks.com reported 2024-12-24 that FTI, NRXP, PBYI, POWL and VMEO have been added to the Zacks Rank #1 (Strong Buy) List on December 24, 2024.
NRXP’s Market Performance
NRX Pharmaceuticals Inc (NRXP) has experienced a 3.05% rise in stock performance for the past week, with a 34.13% rise in the past month, and a 0.60% rise in the past quarter. The volatility ratio for the week is 15.60%, and the volatility levels for the past 30 days are at 10.13% for NRXP. The simple moving average for the past 20 days is 17.89% for NRXP’s stock, with a -36.71% simple moving average for the past 200 days.
NRXP Trading at 21.56% from the 50-Day Moving Average
After a stumble in the market that brought NRXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.59% of loss for the given period.
Volatility was left at 10.13%, however, over the last 30 days, the volatility rate increased by 15.60%, as shares surge +19.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.94% upper at present.
During the last 5 trading sessions, NRXP fell by -4.27%, which changed the moving average for the period of 200-days by -76.53% in comparison to the 20-day moving average, which settled at $1.3257. In addition, NRX Pharmaceuticals Inc saw -63.26% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NRXP starting from Javitt Jonathan C, who purchase 40,000 shares at the price of $1.17 back on Dec 17 ’24. After this action, Javitt Jonathan C now owns 84,634 shares of NRX Pharmaceuticals Inc, valued at $46,800 using the latest closing price.
Stock Fundamentals for NRXP
Current profitability levels for the company are sitting at:
- -2559.5 for the present operating margin
- 0.62 for the gross margin
The net margin for NRX Pharmaceuticals Inc stands at -2547.5. The total capital return value is set at 1.29. Equity return is now at value -682.61, with -231.96 for asset returns.
Based on NRX Pharmaceuticals Inc (NRXP), the company’s capital structure generated -0.55 points at debt to capital in total, while cash flow to debt ratio is standing at -1.85. The debt to equity ratio resting at -0.35. The interest coverage ratio of the stock is -66.05.
Currently, EBITDA for the company is -30.02 million with net debt to EBITDA at -0.26. When we switch over and look at the enterprise to sales, we see a ratio of 3001.34. The receivables turnover for the company is 1.33for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.20.
Conclusion
To wrap up, the performance of NRX Pharmaceuticals Inc (NRXP) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
